In particular, at a molecular level, MALAT1, by targeting serum amyloid antigen 3, a proinflammatory ligand, has been shown to induce the expression of IL-6 and TNF-α, as well as ROS production, thereby promoting endothelial dysfunction (187). Here, IL6 is linked to endothelial dysfunction.